Abstract
This editorial comment focuses upon the idea of offering HAART to all HIV-infected pregnant women including those in developing countries and considers the barriers or problems associated with this concept as well as the positive outcomes. It states that more data is needed but that a strategy would be to ensure that women with CD4 cell count below 350 cells/ml in resource-limited settings receive HAART that would then be continued after breastfeeding cessation for maternal health.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
